The designation "LOC643909" suggests a locus or location on the genome that could potentially encode a protein, but there are no established records of such a gene or the proteins it might express. Nevertheless, if we were to postulate the existence of a protein encoded by a gene locus named LOC643909, then activators of this protein would comprise a series of specific molecules designed to bind to and enhance the protein's activity. These activators could act through various mechanisms, such as directly binding to the active site and promoting a more active conformation, binding to regulatory sites to modulate protein function, or influencing the protein's stability and interaction with other cellular factors.
In the realm of research and development surrounding LOC643909 Activators, scientists would likely deploy an array of experimental techniques to study these activators' interactions with the LOC643909 protein product. Initially, screening assays, possibly high-throughput in nature, would be used to identify molecules with the potential to interact with and activate the LOC643909 protein. These assays could include the use of reporter genes, fluorescence-based activity measurements, or other enzymatic assays designed to detect changes in protein activity. Subsequently, more detailed biochemical studies, such as kinetic analyses, would be performed to understand the nature of the activation process. Further, structural biologists might employ X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy to visualize the interaction between the LOC643909 protein and its activators at the molecular level. This structural data would be critical in revealing the precise binding sites of activators and the conformational changes in the protein that correlate with activation. Complementing experimental approaches, in silico modeling, including molecular docking and dynamics simulations, would provide predictive insights into the binding modes and potential effects of activator binding on the protein's dynamics and function. Together, these methods would yield a detailed understanding of the molecular interactions between LOC643909 Activators and their target protein, contributing to the fundamental knowledge of protein activation mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide interferes with DNA replication and can induce DNA damage responses, potentially affecting cell cycle regulator expression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
As a microtubule-stabilizing agent, Paclitaxel can arrest cells in mitosis, which might upregulate cell cycle regulator proteins. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibitor of DNA topoisomerase I, Camptothecin induces DNA damage and could influence the expression of cell cycle proteins. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
An inhibitor of protein synthesis, which can lead to cellular stress responses and potentially alter the expression of cell cycle regulators. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor, Roscovitine can affect cell cycle progression and the expression of associated proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can impact cell growth and division, thereby potentially affecting cell cycle regulators. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, causing DNA replication stress and possibly influencing cell cycle proteins. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule depolymerizing agent, Nocodazole can arrest cells at mitosis and affect the expression of cell cycle regulators. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
As an indirect antioxidant, sulforaphane can influence cellular stress pathways and potentially modulate protein expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor, Vorinostat can change chromatin structure and gene expression, potentially affecting cell cycle proteins. | ||||||